Skip Navigation
Skip to contents

KDDW 2023


Program at a glance

Home    >    Program    >    Program at a glance
Time / Room Vista 1 Vista 2 Vista 3 Grand 1 Grand 4+5 Walker 1 Walker 2 Art Hall
08:00~08:50 EMW 01 KSNM Clinical aspect of pathophysiology of functional gastrointestinal disorders EMW 02 KCHUGR Lessons from the masters
08:50~09:00
09:00~10:20 Symposium 21 KSG Genomics in gastroenterology Symposium 22 KASL Emerging issue on nonalcoholic fatty liver disease (NAFLD) Symposium 23 KSGC Clinical applications of translational research: current status and future aspect Combined Symposium 01 KSNM+KSGE Endoscopic treatment of functional gastrointestinal disorders Symposium 24 KCHUGR Evolving treatment strategies in advanced gastric cancer Symposium 25 KSGE A review on the management of M3/SM1 esophageal cancer Combined Symposium 02 KPBA+KSGE Recent advances in endoscopic retrograde choangiopan-creatography (ERCP) for surgically altered anatomy PG Course 01 KASID Recent updates in various intestinal disease KOR
10:20~10:40 Coffee Break
10:40~12:00 Combined Symposium 03 KSG+KASID Artificial intelligence in lower gastrointestinal disease Symposium 26 KASL Recent updates of cellular mechanisms and antifibrotic therapy in liver fibrosis KOR Combined Symposium 04 KSGC+KSG Immunotherapy, dawn in a new era of gastrointestinal cancer? Symposium 27 KSGE Application of current image-enhanced endoscopy in upper gastrointestinal disease Combined Symposium 05 KCHUGR+KGCA Optimal approach for upper gastrointestinal subepithelial tumor Symposium 28 KSGE Ongoing issues about gastric endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) Combined Symposium 06 KPBA+KSGE Malignant duodenal and biliary obstruction; various therapeutic strategy PG Course 02 KSNM Case-based learning for gastrointestinal function test KOR
12:00~12:10
12:10~12:50 General Meeting KSG
12:50~13:30 Luncheon Symposium 02

Study of fexuprazan effect in NSAIDs-induced small intestine mucosal injury model
13:30~14:10 Joint Symposium KSG+AGA Advancements in colorectal cancer from early detection to precision therapies Symposium 29 KASL Key questions on the management of hepatocellular carcinoma (HCC) Free Paper 16 LGI 03 Plenary Session 01 KSG Free Paper 18 UGI 03 Symposium 30 KSGE Multidisciplinary management of benign and malignant stricture/obstruction Free Paper 20 PB 01 PG Course 03 KSGC Various problems and appropriate solutions in patients with gastrointestinal cancer KOR
14:10~14:50 Free Paper 17 LGI 04 Plenary Session 02 KSGE Free Paper 19 UGI 04 Free Paper 21 PB 02
14:50~15:10 Coffee Break
15:10~15:50 Symposium 31 KSG Diversity in gastroenterology Symposium 32 KASL Controversial issue on liver disease KOR Free Paper 22 LGI 05 Free Paper 24 PB 03 Free Paper 26 UGI 05 Presidential Lecture 02 KSG 15:10~16:00
15:50~16:30 Free Paper 23 Oncology 03 Free Paper 25 PB 04 Free Paper 27 UGI 06
Supported by Member Societies
Associated Society
Supported by
Endorsed By
Diamond
Platinum
Gold
  • Silver
    Bronze+
    • 동아에스티
    Bronze
    • 길리어드
    • 유한양행
    • 삼성바이오에피스
    • 셀트리온제약(바이오마케팅팀)
    Sapphire+
    • 제일약품
    Sapphire
    • 일동제약
    • 한국에브비
    • 대원제약
    Crystal
    • BMS
    • 부광약품
    • 한미약품
    • 삼일제약
    • 종근당
    Pearl
    • 보령
    • SK케미칼
    • 녹십자웰빙
    • 안국약품
    • 유나이티드
    • 태준제약
    • 펜탁스메디컬
    • 건강약품
    • 에르베메디칼
    • 엠아이텍
    • 중외제약
    • 한국에자이
    • 일양약품
    • 스탠다드싸이텍
    • (주)한국로슈
    • 한국메나리니
    • 명문제약
    • 아이넥스코퍼레이션
    • GC녹십자
    • 조양메디컬
    • Naturlax
    • 파인메딕스
    • 하나제약

    Go to Top

    케이디디더블유 운영협의체

    Business License No.: 609-82-84671

    President: Jae Gyu Kim

    Tel.: 02-459-8252

    E-mail : kddwoffice@gmail.com

    Address : Room 305 Lotte Gold Rose Ⅱ, 31 Seolleung-ro 86 gil, Gangnam-gu, Seoul, 06193, Korea
    KDDW 2023 Secretariat
    Contact (Scientific Program & Abstract) kddwinfo@medioffice.or.kr
    (Registration & Sponsor) Email.kddw2023@medioffice.or.kr